Spencer J. Johnson
Genentech’s Carter ’213 Patent Asserted and Challenged
Biosimilars Law Bulletin ·
Planned Clinical Trial for Aflibercept Signals Likely Future Contests Over Regeneron’s Eylea®
Biosimilars Law Bulletin ·
One of Three Pfizer IPR Petitions Instituted on Rituxan® Patents
Biosimilars Law Bulletin ·